<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Prasanth NV</style></author><author><style face="normal" font="default" size="100%">P Pandian</style></author><author><style face="normal" font="default" size="100%">T Balasubramanian</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of In Vivo Anti Alzheimer's Activity of Vigna radiata and Vigna pilosa using Beta Amyloid Induced Neurotoxicity in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">amyloid-β</style></keyword><keyword><style  face="normal" font="default" size="100%">Vigna pilosa</style></keyword><keyword><style  face="normal" font="default" size="100%">Vigna radiata</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">519-526</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;AD is the most common form of dementia. Extracellular senile (amyloid) plaques and intracellular neurofibrillary tangles (NFTs) are hallmarks of the disease. Vigna radiata and Vigna pilosa are plants used in many Ayurvedic formulations used in the management of dementia and related conditions. The present study was aimed to evaluate the neuroprotective effect of these plants on an amyloid-β (Aβ) 1-42 model of Alzheimer’s disease in rats. Duration of the study was 21 days. After the recovery period post Aβ1-42 ICV administration, from the 8thday, the ethyl acetate extract of Vigna radiata and ethanolic extract of Vigna pilosa (200mg/kg, 400mg/kg), Donepezil (3mg/kg) treatments were made once daily p.o till the 21st day. Cognitive behavioural studies were conducted using radial maze test, Step-through Passive Avoidance Test. The animals were further subjected to euthanasia and the brain were collected and evaluated for antioxidant parameters and brain cytokine levels. The brain tissues were subjected to histopathological examination. The treatment with the extracts significantly improved the cognitive capability of the rats in the Radial arm maze task and step through passive avoidance test. It also reduced oxidative stress, which was evident by the lower levels of lipid peroxide and nitric oxide as well as elevated levels of antioxidant enzymes like catalase, superoxide dismutase and reduced glutathione. The treatment alleviated neuroinflammation in rats by decreasing the concentration of neuroinflammatory markers in a dose-dependent manner. From the results it can be concluded that the plants Vigna radiata and Vigna pilosa has beneficial effects in the improvement of cognitive impairment AD, by reducing oxidative stress and neuroinflammation.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">519</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Prasanth NV&lt;sup&gt;1&lt;/sup&gt;*, P Pandian&lt;sup&gt;1&lt;/sup&gt;, T Balasubramanian&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;1Department of Pharmacy, FEAT, Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu, INDIA.&lt;/p&gt;

&lt;p&gt;2Department of Pharmacology,Al Shifa College of Pharmacy, Perinthalmanna, Kerala, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sharada L. Deore</style></author><author><style face="normal" font="default" size="100%">Anjali A. Kide</style></author><author><style face="normal" font="default" size="100%">Bhushan A. Baviskar</style></author><author><style face="normal" font="default" size="100%">Somshekhar S. Khadabadi</style></author><author><style face="normal" font="default" size="100%">Bhavana A Shende</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Neuroprotective Efficacy of Indian Shankhpushpi Varieties in Alzheimer’s disease – North Vs South</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Dementia</style></keyword><keyword><style  face="normal" font="default" size="100%">Scopolamine</style></keyword><keyword><style  face="normal" font="default" size="100%">Scopoletin.</style></keyword><keyword><style  face="normal" font="default" size="100%">taraxerol</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">372-377</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background&lt;/strong&gt;: Shankhpushpi is a well-known Ayurvedic memory enhancing medicine associated with controversy. Among the various varieties, Convolvulus pleuricaulis and Clitorea ternatia are widely used in commercial memory enhancing formulations under the name of Shankhpushpi. Convolvulus pleuricaulis is recognized as true shankhpushpi in North side of India, however in southern part of India, Clitorea ternatia is accepted as Shankhpushpi. &lt;strong&gt;Objectives:&lt;/strong&gt; The present study aims to compare neuroprotective efficacy of &lt;em&gt;C. pleuricaulis &lt;/em&gt;and &lt;em&gt;C. ternatea&lt;/em&gt; by &lt;em&gt;in vitro&lt;/em&gt;, &lt;em&gt;in vivo &lt;/em&gt;methods and establish scientifically validated data to choose appropriate shankhpushpi variety for commercial use. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Both herbs were extracted in the Soxhlet apparatus with 70% ethanol for 5 - 6 hours at 60 - 65̊ C. The presence of neuroprotective principles - taraxerol and scopoletin in extracts was confirmed by the Thin Layer Chromatography. The preliminary screening for neuroprotective efficacy of extracts was done by in vitro free radical scavenging, Acetyl cholinesterase enzyme inhibition and LOX enzyme level estimation. Invivo study of extracts included behavioral assessment of adult rats by Y maze, Morris water maze using scopolamine induced Alzheimer’s disease like model. &lt;strong&gt;Result: &lt;/strong&gt;Extracts of both &lt;em&gt;C. pleuricaulis&lt;/em&gt; and &lt;em&gt;C. ternatea &lt;/em&gt;significantly scavenged free radicals, inhibited acetyl cholinesterase and LOX enzyme in vitro. But in in-vivo study, significant retention of spatial and working memory was observed in rats administered with &lt;em&gt;C. pleuricaulis&lt;/em&gt; as compared to&lt;em&gt; C. ternatea.&lt;/em&gt; &lt;strong&gt;Conclusion: &lt;/strong&gt;&lt;em&gt;C. pleuricaulis &lt;/em&gt;more significantly shields against memory loss and dementia by reducing oxidative stress, inflammation, and memory impairment. Hence should be used in commericial neuroprotective formulation as chief source of Shankhpushpi instead of &lt;em&gt;C. ternatea.&lt;/em&gt;&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">372</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Sharada L. Deore, Anjali A. Kide*, Bhushan A. Baviskar, Somshekhar S. Khadabadi, Bhavana A Shende&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Government College of Pharmacy, Kathora Naka, Amravati -444601, Maharshtra, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sanjana Datta</style></author><author><style face="normal" font="default" size="100%">Shailendra Patil</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Traditional Herb Extract Salvia officinalis in Treatment of Alzheimers Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Histopathological assessment</style></keyword><keyword><style  face="normal" font="default" size="100%">Locomotor activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Salvia officinalis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February  2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">131-143</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Aim and Objective: &lt;/strong&gt;Alzheimer’s disease is progressive neurodegenerative disorder which affects older individuals. It is the most common cause of dementia and it is associated with the presence of senile plaques which are deposition of beta- amyloidal protein in the hippocampus area of the brain. Medicinal plants have played vital role in world health. In spite of the great advances observed in modern medicine in recent decades, plants still make an important contribution to health care. The present study is done to evaluate &lt;em&gt;Salvia officinalis,&lt;/em&gt; for &lt;em&gt;in vivo &lt;/em&gt;study on Alzheimer’s disease induced mice. &lt;strong&gt;Materials and Methodology: &lt;/strong&gt;Memory Enhancing Activity, Conditioned avoidance test, Y-maze spontaneous alternation test, Elevated Plus Maze, Morris Water Maze, Measurement of Locomotor Activity were done to assess memory and cognitive functioning. The isolated brain homogenate is estimated for reduced glutathione content, Acetyl cholinesterase Activity, Superoxide dismutase assay (SOD), Lipid peroxidation assay (TBARS), Glutathione peroxidase assay (GSH-Px) and Histopathology examination of brain was performed and analyzed. &lt;strong&gt;Results and Discussion: &lt;/strong&gt;The elevated level of enzymes and decreased level of tissue antioxidant markers were observed in treatment comparative to piracetam treatment group. While 300 mg/kg extract significantly reduced the elevated levels of the enzymes and also significantly increased the tissue antioxidant levels, while decreased the glutathione levels when compared with the control. &lt;strong&gt;Conclusion: &lt;/strong&gt;The histopathological study confirmed the recovery. The herbal extract (150 and 300 mg/kg) has shown effectiveness against Alzheimer’s disease.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">131</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Sanjana Datta*, Shailendra Patil&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;SVN Institute of Pharmaceutical Sciences, Swami Vivekanand University, Sagar (MP) 470228, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aslam Pathan</style></author><author><style face="normal" font="default" size="100%">Abdulrahman Alshahrani</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neuroprotective Effects of Valeriana wallichii on Scopolamine Induced Learning and Memory Impairment in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Elevated Plus Maze</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Scopolamine</style></keyword><keyword><style  face="normal" font="default" size="100%">Valeriana wallichii</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s38-s41</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Alzheimer&amp;rsquo;s disease (AD) is the most common cause of dementia in worldwide, treatment options is extremely limited and costly. The present study was conducted to investigate and validate the traditional claim of &lt;em&gt;Valeriana wallichii&lt;/em&gt; on scopolamine treated rats as an AD model. &lt;strong&gt;Methods:&lt;/strong&gt; The &lt;em&gt;Valeriana wallichii&lt;/em&gt; rhizome ethanol extract (25 mg/kg/day) was administered daily along with scopolamine for a period of 14 days following which the elevated plus maze test were performed to assess learning and memory. Rats treated with scopolamine or vehicle only were also included in the experiment. &lt;strong&gt;Result:&lt;/strong&gt; The study demonstrate that scopolamine treatment resulted in learning and memory deficits which were partially and significantly ameliorated by the &lt;em&gt;Valeriana wallichii&lt;/em&gt; rhizome ethanol extract.&lt;strong&gt; Conclusion:&lt;/strong&gt; The study demonstrates the ability of the&lt;em&gt; Valeriana wallichii&lt;/em&gt; rhizome ethanol extract to reverse scopolamine-induced learning and memory deficits in rats.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">s38</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aslam Pathan&lt;sup&gt;1,*&lt;/sup&gt;, Abdulrahman Alshahrani&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology and Therapeutics College of Medicine, Shaqra University, Ministry of Higher Education, Shaqra-11961, KINGDOM OF SAUDI ARABIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Internal Medicine (Neurology), College of Medicine, Shaqra University, Ministry of Higher Education, Shaqra-11961, KINGDOM OF SAUDI ARABIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lakshmi.T</style></author><author><style face="normal" font="default" size="100%">Rajendran.R</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Acetyl cholinesterase inhibitory assay of Acacia catechu Willd ethanolic seed extract</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acacia catechu seed</style></keyword><keyword><style  face="normal" font="default" size="100%">Acetyl cholinesterase inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Spectrophotometric analysis.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">9th June 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">1-1</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aim &amp;amp; objective:&lt;/strong&gt; The aim of this study was to evaluate acetyl cholinesterase inhibitory activity of &lt;em&gt;Acacia catechu&lt;/em&gt; ethanolic seed extract to introduce a new source for management of Alzheimer&amp;rsquo;s disease. &lt;strong&gt;Background&lt;/strong&gt;: Alzheimer&amp;rsquo;s disease is a complex, multifactorial, progressive, neurodegenerative disease primarily affecting the elderly population and is estimated to account for 50&amp;ndash;60% of dementia cases in persons over 65 years of age. It is likely that the inhibition of acetyl cholinesterase by&lt;em&gt; Acacia catechu&lt;/em&gt; ethanolic seed extract that is rich in flavonoids and antioxidants may aid in the protection of neurodegenerative disorders and ultimately Alzheimer&amp;#39;s disease. &lt;strong&gt;Methods:&lt;/strong&gt; Anti cholinesterase activity is determined by adopting &lt;em&gt;In vitro&lt;/em&gt; standard protocol. &lt;strong&gt;Results:&lt;/strong&gt; According to the obtained results, the inhibitory activity (IC&lt;sub&gt;50&lt;/sub&gt; values, &amp;mu;g /ml) of extracts was 204.38 &amp;plusmn; 2.54 &amp;micro; g/ml. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results indicated and confirmed the traditional use of &lt;em&gt;Acacia catechu&lt;/em&gt; ethanolic seed extract for management of central nervous system disorders. It showed the moderate activity in inhibition of acetyl cholinesterase at various concentrations. However, further investigations on identification of active components in the extracts are needed.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Key words&lt;/strong&gt;: &lt;em&gt;Acacia catechu&lt;/em&gt; seed, Acetyl cholinesterase inhibitor, Alzheimer&amp;rsquo;s disease, spectrophotometric analysis.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Lakshmi. T &lt;sup&gt;*1&lt;/sup&gt;, Rajendran. R &lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Assistant professor ,Department of Pharmacology ,Saveetha Dental College &amp;amp; Hospitals, Chennai, India.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Green Chem Herbal Extracts &amp;amp; Formulations,Bangalore,India.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lakshmi Thangavelu</style></author><author><style face="normal" font="default" size="100%">Rajendran Ramasamy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Acetyl Cholinesterase Inhibitory assay of Acacia catechu Willd Ethanolic Seed Extract</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acacia catechu seed</style></keyword><keyword><style  face="normal" font="default" size="100%">Acetyl cholinesterase inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurodegenerative</style></keyword><keyword><style  face="normal" font="default" size="100%">Spectrophotometric analysis.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">01/2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">280-282</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aim &amp;amp; objective:&lt;/strong&gt; The aim of this study was to evaluate acetyl cholinesterase inhibitory activity of &lt;em&gt;Acacia catechu &lt;/em&gt;ethanolic seed extract to introduce a new source for management of Alzheimer&amp;rsquo;s disease. &lt;strong&gt;Background:&lt;/strong&gt; Alzheimer&amp;rsquo;s disease is a complex, multifactorial, progressive, neurodegenerative disease primarily affecting the elderly population and is estimated to account for 50&amp;ndash;60% of dementia cases in persons over 65 years of age. It is likely that the inhibition of acetyl cholinesterase by &lt;em&gt;Acacia catechu&lt;/em&gt; ethanolic seed extract that is rich in flavonoids and antioxidants may aid in the protection of neurodegenerative disorders and ultimately Alzheimer&amp;rsquo;s disease. &lt;strong&gt;Methods:&lt;/strong&gt; Anti cholinesterase activity is determined by adopting &lt;em&gt;In vitro &lt;/em&gt;standard protocol. &lt;strong&gt;Results:&lt;/strong&gt; According to the obtained results, the inhibitory activity (IC&lt;sub&gt;50&lt;/sub&gt; values, &amp;mu;g /ml) of extracts was 204.38 &amp;plusmn; 2.54 &amp;mu;g/ ml. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results indicated and confirmed the traditional use of &lt;em&gt;Acacia catechu&lt;/em&gt; ethanolic seed extract for management of central nervous system disorders. It showed the moderate activity in inhibition of acetyl cholinesterase at various concentrations. However, further investigations on identification of active components in the extracts are needed.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">280</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Lakshmi Thangavelu&lt;sup&gt;*1&lt;/sup&gt; and Rajendran Ramasamy&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Saveetha Dental College and Hospitals, Chennai, India.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Green Chem Herbal Extracts and Formulations, Bangalore, India.&lt;/p&gt;</style></auth-address></record></records></xml>